Catheter Precision Inc Revenue Growth Rates (VTAK), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Catheter Precision Inc   (NYSEAMER: VTAK)
 

VTAK's Revenue Growth by Quarter and Year

Catheter Precision Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VTAK Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 1.02
1st Quarter March 0.43
FY 1.45

VTAKs Annual Revenue
Catheter Precision Inc 's Revenue in the fiscal year 2025 $ 0.82 millions
Catheter Precision Inc 's Revenue in the fiscal year 2024 $ 0.42 millions
Catheter Precision Inc 's Revenue in the fiscal year 2023 $ 0.44 millions
Catheter Precision Inc 's Revenue in the fiscal year 2022 $ 0.01 millions
Catheter Precision Inc 's Revenue in the fiscal year 2021 $ 0.02 millions




VTAK Revenue second quarter 2026 Y/Y Growth Comment
Catheter Precision Inc reported Revenue surge of 385.24% year on year in the second quarter 2026, to $ 1.02 millions, this is lower than Catheter Precision Inc 's recent average Revenue surge of 2.4595658764946E+17%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 2 other companies have achieved higher Revenue growth. While Catheter Precision Inc ' s Revenue doubling of 385.24% ranks overall at the positon no. 90 in the second quarter 2026.


VTAK Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 60 % 15.38 % -
3rd Quarter September - 130 % -23.08 % -
2nd Quarter June 385.24 % 133.33 % -10 % 900 %
1st Quarter March 207.14 % 75 % -11.11 % 800 %
FY   - 95.24 % -6.67 % -

Financial Statements
Catheter Precision Inc 's second quarter 2026 Revenue $ 1.02 millions VTAK's Income Statement
Catheter Precision Inc 's second quarter 2025 Revenue $ 0.21 millions Quarterly VTAK's Income Statement


VTAK Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 4.35 % 50 % 0 %
3rd Quarter September - 9.52 % 11.11 % 30 %
2nd Quarter June 136.98 % 50 % 12.5 % 11.11 %
1st Quarter March 79.17 % -6.67 % -38.46 % -
FY (Year on Year)   - 95.24 % -6.67 % -


Back to VTAK Growth rate Comparisons >> Back to VTAK Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #3
Healthcare Sector #30
Overall #90

Revenue Y/Y Growth Statistics
High Average Low
1.0E+17 % 2.4595658764946E+17 % -100 %
(Jun 30 2026)   (Jun 30 2022)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #3
Healthcare Sector #30
Overall #90
Revenue Y/Y Growth Statistics
High Average Low
1.0E+17 % 2.4595658764946E+17 % -100 %
(Jun 30 2026)   (Jun 30 2022)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Catheter Precision Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
1.0E+17 % 1.7499701409211E+17 % -100 %
 


VTAK's II. Quarter Q/Q Revenue Comment
Catheter Precision Inc achieved in the II. Quarter 2026 below company average Revenue doubling of 136.98% quarter on quarter, to $ 1.02 millions.

Although the II. Quarter 2026 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the II. Quarter surge, eclipses the 50% growth in the II. Quarter a year ago

Within Medical Equipment & Supplies industry 8 other companies have achieved higher Revenue quarter on quarter growth. While Catheter Precision Inc 's Revenue growth quarter on quarter, overall rank is 115.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #9
Healthcare Sector #38
Overall #115
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #9
Healthcare Sector #38
Overall #115
Revenue Q/Q Growth Statistics
High Average Low
1.0E+17 % 1.7499701409211E+17 % -100 %
 


VTAK's II. Quarter Q/Q Revenue Comment
Catheter Precision Inc achieved in the II. Quarter 2026 below company average Revenue doubling of 136.98% quarter on quarter, to $ 1.02 millions.

II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 50% in the II. Quarter a year ago.

Within Medical Equipment & Supplies industry 8 other companies have achieved higher Revenue quarter on quarter growth. While Catheter Precision Inc 's Revenue growth quarter on quarter, overall rank is 115.


Catheter Precision Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 1.91 $ 1.11 $ 0.82 $ 0.73 $ 0.60
Y / Y Revenue Growth (TTM) 219.17 % 130.35 % 95 % 82.96 % 37.61 %
Year on Year Revenue Growth Overall Ranking # 448 # 1305 # 2559 # 445 # 405
Seqeuential Revenue Change (TTM) 72.83 % 35.29 % 12.19 % 21.67 % 24.74 %
Seq. Revenue Growth (TTM) Overall Ranking # 689 # 966 # 1637 # 2733 # 2148


Cumulative Revenue growth Comment
With 219.17% annual Revenue growth, Catheter Precision Inc would report a record annual Revenue surge if the fiscal year would end on Jun 30 2026.

In the Healthcare sector 107 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 448, from total ranking in previous quarter at 1305.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 42
Healthcare Sector # 108
Overall # 448

Revenue TTM Y/Y Growth Statistics
High Average Low
219.17 %
 11.14 %
-99.44 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 42
Sector # 143
S&P 500 # 689
Cumulative Revenue growth Comment
With 219.17% annual Revenue growth, Catheter Precision Inc would report a record annual Revenue surge if the fiscal year would end on Jun 30 2026.

In the Healthcare sector 107 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 448, from total ranking in previous quarter at 1305.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 42
Healthcare Sector # 108
Overall # 448

Revenue TTM Y/Y Growth Statistics
High Average Low
219.17 %
11.14 %
-99.44 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 42
Sector # 143
S&P 500 # 689




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
VTAK's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue surge for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Nuvation Bio Inc 644.35%$ 644.350 millions
Tonix Pharmaceuticals Holding Corp 577.88%$ 577.878 millions
Allogene Therapeutics Inc 567.50%$ 567.500 millions
Brightspring Health Services Inc 555.52%$ 555.518 millions
Bullfrog Ai Holdings Inc 547.64%$ 547.638 millions
Northwest Biotherapeutics Inc516.03%$ 516.031 millions
Vistagen Therapeutics Inc 504.92%$ 504.918 millions
Kymera Therapeutics Inc 466.40%$ 466.399 millions
Surrozen Inc 408.65%$ 408.647 millions
Regenxbio Inc 405.73%$ 405.731 millions
Insmed Inc393.78%$ 393.775 millions
Omeros Corporation387.10%$ 387.096 millions
Catheter Precision Inc 380.66%$ 380.660 millions
Macrogenics Inc 377.97%$ 377.974 millions
Vireo Growth Inc.335.47%$ 335.470 millions
Dianthus Therapeutics Inc 294.30%$ 294.301 millions
Miragen Therapeutics Inc 278.67%$ 278.667 millions
Alpha Cognition Inc.267.56%$ 267.556 millions
Agios Pharmaceuticals Inc 259.25%$ 259.253 millions
Omniab Inc 244.24%$ 244.239 millions
Medicinova Inc 240.60%$ 240.596 millions
Clene Inc 233.33%$ 233.333 millions
Editas Medicine Inc 232.31%$ 232.309 millions
Urogen Pharma Ltd 206.17%$ 206.174 millions
Sintx Technologies Inc 199.34%$ 199.338 millions


About Catheter Precision Inc Revenue Growth Rates (VTAK), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Catheter Precision Inc (CIK 1716621).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001437749-26-028024
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Catheter Precision Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.